NIR-light active hybrid nanoparticles for combined imaging and bimodal therapy of cancerous cells

被引:21
作者
Topete, A. [1 ]
Melgar, D. [1 ]
Alatorre-Meda, M. [1 ]
Iglesias, P. [2 ]
Argibay, B. [3 ]
Vidawati, S. [1 ]
Barbosa, S. [1 ]
Costoya, J. A. [2 ]
Taboada, P. [1 ]
Mosquera, V. [1 ]
机构
[1] Univ Santiago de Compostela, Dept Fis Mat Condensada, Grp Fis Coloides & Polimeros, Santiago De Compostela 15782, Spain
[2] Univ Santiago de Compostela, Ctr Invest Med Mol & Enfermedades Cron CIMUS, Mol Oncol Grp, Santiago De Compostela 15782, Spain
[3] Univ Santiago de Compostela, Hosp Clin, Lab Invest Neurociencias Clin, Santiago De Compostela 15782, Spain
关键词
PLGA-BASED NANOPARTICLES; INDOCYANINE GREEN ICG; IN-VITRO; POLYMER NANOPARTICLES; DESIGNED FABRICATION; DELIVERY-SYSTEM; DRUG-DELIVERY; RELEASE; TUMOR; BIODISTRIBUTION;
D O I
10.1039/c4tb01273a
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
We report the synthesis of a multifunctional biocompatible theranostic nanoplatform consisting of a biodegradable PLGA matrix surface-functionalized with indocyanine green (ICG), a near-IR fluorescent dye, and co-loaded with superparamagnetic iron oxide nanoparticles (SPIONs) and the anticancer drug doxorubicin (DOXO). Combination of chemo-and photothermal therapeutic efficacy as well as magnetic resonance and optical fluorescence imaging performance were successfully tested in vitro on a tumoral cervical HeLa cell line. Magnetic in vitro guided targeting of these nanoplatforms was also proven. These nanoconstructs also enabled to monitor their in vivo biodistribution by fluorescence imaging in a mice model, which revealed their effective accumulation in the tumor and, unexpectedly, in the brain area. A lower presence of nanoplatforms was noted in the reticulo-endothelial system. The present observations suggest the nanoplatforms ability to possibly overcome the blood brain barrier. These results open up new possibilities to use our multifunctional nanoplatforms to treat brain-located diseases.
引用
收藏
页码:6967 / 6977
页数:11
相关论文
共 62 条
[1]   PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect [J].
Acharya, Sarbari ;
Sahoo, Sanjeeb K. .
ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (03) :170-183
[2]   Biodegradable polymer matrix nanocomposites for tissue engineering: A review [J].
Armentano, I. ;
Dottori, M. ;
Fortunati, E. ;
Mattioli, S. ;
Kenny, J. M. .
POLYMER DEGRADATION AND STABILITY, 2010, 95 (11) :2126-2146
[3]   PLGA nanoparticles in drug delivery: The state of the art [J].
Bala, I ;
Hariharan, S ;
Kumar, MNVR .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2004, 21 (05) :387-422
[4]   Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol [J].
Budhian, A ;
Siegel, SJ ;
Winey, KI .
JOURNAL OF MICROENCAPSULATION, 2005, 22 (07) :773-785
[5]   Doxorubicin-loaded micelles of reverse poly(butylene oxide)-poly(ethylene oxide)-poly(butylene oxide) block copolymers as efficient "active" chemotherapeutic agents [J].
Cambon, A. ;
Rey-Rico, A. ;
Mistry, D. ;
Brea, J. ;
Loza, M. I. ;
Attwood, D. ;
Barbosa, S. ;
Alvarez-Lorenzo, C. ;
Concheiro, A. ;
Taboada, P. ;
Mosquera, V. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 445 (1-2) :47-57
[6]   PLGA-based nanoparticles: An overview of biomedical applications [J].
Danhier, Fabienne ;
Ansorena, Eduardo ;
Silva, Joana M. ;
Coco, Regis ;
Le Breton, Aude ;
Preat, Veronique .
JOURNAL OF CONTROLLED RELEASE, 2012, 161 (02) :505-522
[7]   Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography [J].
Desmettre, T ;
Devoisselle, JM ;
Mordon, S .
SURVEY OF OPHTHALMOLOGY, 2000, 45 (01) :15-27
[8]  
DICKSON RB, 1986, CANCER RES, V46, P1707
[9]   Nanomedicine: Developing smarter therapeutic and diagnostic modalities [J].
Farokhzad, Omid C. ;
Langer, Robert .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (14) :1456-1459
[10]   New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? [J].
Feng, Si-Shen .
NANOMEDICINE, 2006, 1 (03) :297-309